NITROGLYCERIN injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

nitroglycerin injection, solution

american regent, inc. - nitroglycerin (unii: g59m7s0ws3) (nitroglycerin - unii:g59m7s0ws3) - nitroglycerin 5 mg in 1 ml - nitroglycerin injection is indicated for treatment of peri-operative hypertension; for control of congestive heart failure in the setting of acute myocardial infarction; for treatment of angina pectoris in patients who have not responded to sublingual nitroglycerin and β -blockers; and for induction of intraoperative hypotension. allergic reactions to organic nitrates are extremely rare, but they do occur. nitroglycerin injection is contraindicated in patients who are allergic to it. in patients with pericardial tamponade, restrictive cardiomyopathy, or constrictive pericarditis, cardiac output is dependent upon venous return. intravenous nitroglycerin is contraindicated in patients with these conditions.

AMINOCAPROIC ACID injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

aminocaproic acid injection, solution

american regent, inc. - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid injection is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures), and portacaval shunt; hematological disorders such as aplastic anemia; acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usually a normal physiological phenomenon, may frequently be associated with life-threatening complications following severe trauma, anoxia, and shock.  symptomatic of such complications is surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system).  (see warnings.) aminocaproic acid should

AMINOCAPROIC ACID injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

aminocaproic acid injection, solution

american regent, inc. - aminocaproic acid (unii: u6f3787206) (aminocaproic acid - unii:u6f3787206) - aminocaproic acid 250 mg in 1 ml - aminocaproic acid injection is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. in life-threatening situations, fresh whole blood transfusions, fibrinogen infusions, and other emergency measures may be required. fibrinolytic bleeding may frequently be associated with surgical complications following heart surgery (with or without cardiac bypass procedures), and portacaval shunt; hematological disorders such as aplastic anemia; acute and life-threatening abruptio placentae; hepatic cirrhosis; and neoplastic disease such as carcinoma of the prostate, lung, stomach, and cervix. urinary fibrinolysis, usually a normal physiological phenomenon, may frequently be associated with life-threatening complications following severe trauma, anoxia, and shock.  symptomatic of such complications is surgical hematuria (following prostatectomy and nephrectomy) or nonsurgical hematuria (accompanying polycystic or neoplastic diseases of the genitourinary system).  (see warnings.) aminocaproic acid should

CHLOROTHIAZIDE SODIUM injection, powder, lyophilized, for solution Bandaríkin - enska - NLM (National Library of Medicine)

chlorothiazide sodium injection, powder, lyophilized, for solution

american regent, inc. - chlorothiazide sodium (unii: sn86fg7n2k) (chlorothiazide - unii:77w477j15h) - chlorothiazide 500 mg in 18 ml - chlorothiazide sodium for injection, usp is indicated as adjunctive therapy in edema associated with congestive heart failure, hepatic cirrhosis, and corticosteroid and estrogen therapy. chlorothiazide sodium for injection, usp has also been found useful in edema due to various forms of renal dysfunction such as nephrotic syndrome, acute glomerulonephritis, and chronic renal failure. routine use of diuretics during normal pregnancy is inappropriate and exposes mother and fetus to unnecessary hazard. diuretics do not prevent development of toxemia of pregnancy and there is no satisfactory evidence that they are useful in the treatment of toxemia. edema during pregnancy may arise from pathologic causes or from the physiologic and mechanical consequences of pregnancy. thiazides are indicated in pregnancy when edema is due to pathologic causes, just as they are in the absence of pregnancy (see precautions, pregnancy ). dependent edema in pregnancy, resulting from restriction of venous return by the gravid uterus,

FOMEPIZOLE injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

fomepizole injection, solution

american regent, inc. - fomepizole (unii: 83lcm6l2by) (fomepizole - unii:83lcm6l2by) - fomepizole injection is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis (see dosage and administration). fomepizole injection should not be administered to patients with a documented serious hypersensitivity reaction to fomepizole injection or other pyrazoles.

FOMEPIZOLE injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

fomepizole injection, solution

american regent, inc. - fomepizole (unii: 83lcm6l2by) (fomepizole - unii:83lcm6l2by) - fomepizole injection is indicated as an antidote for ethylene glycol (such as antifreeze) or methanol poisoning, or for use in suspected ethylene glycol or methanol ingestion, either alone or in combination with hemodialysis (see dosage and administration). fomepizole injection should not be administered to patients with a documented serious hypersensitivity reaction to fomepizole injection or other pyrazoles.

NICARDIPINE HYDROCHLORIDE injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

nicardipine hydrochloride injection, solution

american regent, inc. - nicardipine hydrochloride (unii: k5bc5011k3) (nicardipine - unii:cz5312222s) - nicardipine hydrochloride 2.5 mg in 1 ml - nicardipine hydrochloride injection, usp is indicated for the short-term treatment of hypertension when oral therapy is not feasible or not desirable.  for prolonged control of blood pressure, transfer patients to oral medication as soon as their clinical condition permits [see dosage and administration (2.1)] . nicardipine hydrochloride injection is contraindicated in patients with advanced aortic stenosis because part of the effect of nicardipine hydrochloride injection is secondary to reduced afterload.  reduction of diastolic pressure in these patients may worsen rather than improve myocardial oxygen balance. pregnancy category c there are no adequate and well-controlled studies of nicardipine use in pregnant women. however, limited human data in pregnant women with preeclampsia or pre-term labor are available. in animal studies, no embryotoxicity occurred in rats with oral doses 8 times the maximum recommended human dose (mrhd) based on body surface area (mg/m2 ), but did occur in rabbits with oral doses

SELENIUM injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

selenium injection, solution

american regent, inc. - selenious acid (unii: f6a27p4q4r) (selenious acid - unii:f6a27p4q4r) - selenious acid 65.4 ug in 1 ml - selenium injection is indicated for use as a supplement to intravenous solutions given for total parenteral nutrition (tpn). administration of selenium in tpn solutions helps to maintain plasma selenium levels and to prevent depletion of endogenous stores and subsequent deficiency symptoms. selenium injection should not be given undiluted by direct injection into a peripheral vein because of the potential for infusion phlebitis.

PAPAVERINE HYDROCHLORIDE injection, solution Bandaríkin - enska - NLM (National Library of Medicine)

papaverine hydrochloride injection, solution

american regent, inc. - papaverine hydrochloride (unii: 23473ec6bq) (papaverine - unii:daa13nkg2q) - papaverine hydrochloride 30 mg in 1 ml - papaverine is recommended in various conditions accompanied by spasm of smooth muscle, such as vascular spasm associated with acute myocardial infarction (coronary occlusion), angina pectoris, peripheral and pulmonary embolism, peripheral vascular disease in which there is a vasospastic element, or certain cerebral angiospastic states; and visceral spasm, as in ureteral, biliary, or gastrointestinal colic. intravenous injection of papaverine is contraindicated in the presence of complete atrioventricular heart block. when conduction is depressed, the drug may produce transient ectopic rhythms of ventricular origin, either premature beats or paroxysmal tachycardia. papaverine hydrochloride is not indicated for the treatment of impotence by intracorporeal injection. the intracorporeal injection of papaverine hydrochloride has been reported to have resulted in persistent priapism requiring medical and surgical intervention. drug dependence resulting from the abuse of many of the selective depressants, includin

BETAMETHASONE SODIUM PHOSPHATE AND BETAMETHASONE ACETATE injection, suspension Bandaríkin - enska - NLM (National Library of Medicine)

betamethasone sodium phosphate and betamethasone acetate injection, suspension

american regent, inc. - betamethasone acetate (unii: ti05ao53l7) (betamethasone - unii:9842x06q6m), betamethasone sodium phosphate (unii: 7bk02scl3w) (betamethasone - unii:9842x06q6m) - betamethasone acetate 3 mg in 1 ml - when oral therapy is not feasible, the intramuscular use of betamethasone sodium phosphate and betamethasone acetate injectable suspension is indicated as follows: allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma, atopic dermatitis, contact dermatitis, drug hypersensitivity reactions, perennial or seasonal allergic rhinitis, serum sickness, transfusion reactions. dermatologic diseases bullous dermatitis herpetiformis, exfoliative erythroderma, mycosis fungoides, pemphigus, severe erythema multiforme (stevens-johnson syndrome). endocrine disorders congenital adrenal hyperplasia, hypercalcemia associated with cancer, nonsuppurative thyroiditis. hydrocortisone or cortisone is the drug of choice in primary or secondary adrenocortical insufficiency.  synthetic analogs may be used in conjunction with mineralocorticoids where applicable; in infancy mineralocorticoid supplementation is of particular importance. gastrointesti